Table 3.
Table 3 Top 5 Disease–Drug Associations
| RCT/MeSH |
RCT/UMLS |
DSUM/UMLS 2004 |
||||||
|---|---|---|---|---|---|---|---|---|
| Disease | Drug | Start Year | ɛ(χ2) | Drug | Start Year | ɛ(χ2) | Drug | ɛ(χ2) |
| Acquired immunodeficiency syndrome | zidovudine | 1987 | 0.63153 | zidovudine | 1987 | 0.90564 | ritonavir | 0.74390 |
| didanosine | 1992 | 0.25971 | didanosine | 1992 | 0.53224 | lamivudine | 0.74145 | |
| zalcitabine | 1989 | 0.25482 | lamivudine | 1994 | 0.50146 | lopinavir | 0.64139 | |
| foscarnet | 1986 | 0.22152 | stavudine | 1993 | 0.47512 | lopinavir-ritonavir | 0.63180 | |
| pentamidine | 1976 | 0.19434 | ritonavir | 1995 | 0.42316 | zidovudine | 0.63027 | |
| Asthma | albuterol | 1972 | 0.80320 | albuterol | 1971 | 0.64084 | albuterol | 0.78789 |
| budesonide | 1980 | 0.50067 | salmeterol | 1988 | 0.47005 | montelukast | 0.55013 | |
| beclomethasone | 1973 | 0.48950 | methacholine | 1976 | 0.46152 | montelukast sodium | 0.54505 | |
| terbutaline | 1973 | 0.43036 | budesonide | 1980 | 0.43908 | ipratropium | 0.41305 | |
| methacholine chloride | 1983 | 0.42112 | montelukast | 1996 | 0.40051 | fluticasone | 0.40265 | |
| Breast neoplasms | tamoxifen | 1976 | 0.90979 | tamoxifen | 1973 | 0.71016 | tamoxifen | 0.40440 |
| cyclophosphamide | 1966 | 0.58549 | cyclophosphamide | 1966 | 0.36420 | anastrozole | 0.34439 | |
| fluorouracil | 1967 | 0.55386 | fluorouracil | 1969 | 0.30104 | letrozole | 0.30108 | |
| methotrexate | 1965 | 0.39540 | anastrozole | 1996 | 0.25993 | trastuzumab | 0.23170 | |
| epirubicin | 1984 | 0.38076 | toremifene | 1990 | 0.23456 | exemestane | 0.22265 | |
| Congestive heart failure | digoxin | 1971 | 0.31366 | digoxin | 1971 | 0.28106 | frusemide | 0.74348 |
| enalapril | 1982 | 0.26417 | frusemide | 1965 | 0.17439 | carvedilol | 0.50234 | |
| captopril | 1979 | 0.25010 | dobutamine | 1979 | 0.17096 | digoxin | 0.49833 | |
| furosemide | 1965 | 0.23694 | enalapril | 1982 | 0.16701 | lisinopril | 0.38617 | |
| milrinone | 1985 | 0.22112 | captopril | 1979 | 0.15419 | spironolactone | 0.32166 | |
| Diabetes mellitus | insulin | 1965 | 1.00000 | insulin | 1965 | 0.95470 | metformin | 0.69717 |
| glyburide | 1974 | 0.51144 | glyburide | 1970 | 0.44653 | insulin isophane | 0.63515 | |
| metformin | 1969 | 0.44713 | metformin | 1970 | 0.40722 | metformin hydrochloride | 0.49561 | |
| insulin, isophane | 1982 | 0.35043 | insulin, regular, human | 1982 | 0.35550 | glipizide | 0.47934 | |
| glucagon | 1970 | 0.31428 | rosiglitazone | 1999 | 0.34800 | glyburide | 0.43595 | |
| Parkinson’s disease | levodopa | 1971 | 1.00000 | levodopa | 1970 | 1.00000 | carbidopa | 1.00000 |
| carbidopa | 1975 | 0.62779 | carbidopa | 1973 | 0.58552 | levodopa | 1.00000 | |
| selegiline | 1980 | 0.53362 | entacapone | 1994 | 0.46421 | pramipexol | 0.36856 | |
| bromocriptine | 1976 | 0.42983 | selegiline | 1987 | 0.45679 | entacapone | 0.29354 | |
| benserazide | 1976 | 0.32870 | pramipexol | 1995 | 0.42478 | ropinirole | 0.27994 | |
| Pneumonia | cefamandole | 1978 | 0.19196 | ceftazidime | 1983 | 0.19061 | azithromycin | 0.61668 |
| cefoperazone | 1983 | 0.15708 | azithromycin | 1990 | 0.18618 | ceftriaxon | 0.48426 | |
| ceftazidime | 1983 | 0.14577 | telithromycin | 2000 | 0.16826 | ipratropium | 0.34349 | |
| erythromycin | 1966 | 0.14514 | ceftriaxon | 1981 | 0.16452 | albuterol | 0.34127 | |
| roxithromycin | 1990 | 0.13789 | imipenem | 1983 | 0.15372 | ipratropium bromide | 0.33408 | |
| Schizophrenia | haloperidol | 1970 | 0.88813 | haloperidol | 1970 | 0.75683 | benztropine | 0.32158 |
| risperidone | 1989 | 0.62936 | olanzapine | 1996 | 0.75337 | benzatropine methanesulfonate | 0.30715 | |
| clozapine | 1978 | 0.58340 | risperidone | 1992 | 0.65631 | olanzapine | 0.27719 | |
| fluphenazine | 1967 | 0.46367 | clozapine | 1978 | 0.59956 | risperidone | 0.24228 | |
| pirenzepine | 1980 | 0.37131 | quetiapine | 1996 | 0.37114 | fluphenazine hydrochloride | 0.23775 | |
This table presents the generic name drugs most associated with the diseases as identified in Medline RCT articles (annotated by MeSH and UMLS concepts with BioMedLEE) and discharge summaries (annotated by UMLS concepts with MedLEE). For RCT/MeSH and RCT/UMLS, the start year indicates the year the drug first appeared in the literature based on the respective annotations; for DSUM/UMLS, the start year is the year of discharge summaries (in this case, 2004).